Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-18Jun-30-18Mar-31-18Dec-31-17Sep-30-17Jun-30-17Mar-31-17Dec-31-16
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  32.851.051.051.089.957.125.90.0
Depreciation and amortization   [+]-40.9-25.1-8.30.4-9.737.540.345.4
Asset impairment charges  18.6  18.553.8  56.1
Stock-based compensation  1.92.02.12.52.64.13.52.7
Deferred taxes     -0.2   -0.2
Change in working capital   [+]1.8-9.9-18.3-16.74.231.838.525.3
Other operating activities  -36.1-41.1-50.3-61.4-143.3-191.3-160.7-128.4
Cash from operations  -22.1-4.8-5.4-5.9-2.8-4.93.51.0
   
Capital expenditures   [+]-0.2-0.10.00.00.0-1.9-1.9-1.7
Acquisitions  -69.2      -0.6
Other cash from investing     2.0    
Cash from investing  -66.92.32.02.00.00.00.0-0.3
   
Repurchase of common stock, net   0.5 0.0-17.2  -11.4
Financing costs    -13.8-13.6-13.6   
Other cash from financing  86.7-6.2-6.2-13.25.21.41.4-1.7
Cash from financing  86.28.17.60.41.6-9.9-9.9-13.0
   
Free cash flow  -22.3-5.0-5.4-6.0-2.9-6.81.5-0.7
        Per share (diluted)  ($1.86)($0.39)($0.44)($0.50)($0.26)($0.74)$0.19($0.10)
   
Cash paid for interest  27.628.228.828.528.829.126.227.3
Cash paid for income taxes  0.00.0-0.3-0.9-2.2-5.9-5.7-4.9

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy